Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 09:17 am Purchase | 2025-09-30 | 13G | iBio, Inc. IBIO | Adage Capital Management, L.P. | 2,181,422 9.990% | 2,181,422 (New Position) | Filing History |
| 2025-11-13 09:16 am Purchase | 2025-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO | Adage Capital Management, L.P. | 5,517,650 9.990% | 5,517,650 (New Position) | Filing History |
| 2025-11-13 09:15 am Sale | 2025-09-30 | 13G | Sitio Royalties Corp. STR | Adage Capital Management, L.P. | 0 0.000% | -6,263,396 (Position Closed) | Filing History |
| 2025-11-13 09:13 am Sale | 2025-09-30 | 13G | Dynamix Corporation Class A Ordinary Shares ETHM | Adage Capital Management, L.P. | 125,000 0.750% | -1,225,000 (-90.74%) | Filing History |
| 2025-11-13 09:11 am Purchase | 2025-09-30 | 13G | Equillium, Inc. EQ | Adage Capital Management, L.P. | 6,012,624 9.990% | 6,012,624 (New Position) | Filing History |
| 2025-11-13 09:10 am Purchase | 2025-09-30 | 13G | Abeona Therapeutics Inc. ABEO | Adage Capital Management, L.P. | 5,352,996 9.990% | 941,424 (+21.34%) | Filing History |
| 2025-11-13 09:10 am Purchase | 2025-09-30 | 13G | Milestone Pharmaceuticals Inc. MIST | Adage Capital Management, L.P. | 8,659,064 9.990% | 8,659,064 (New Position) | Filing History |
| 2025-11-13 09:08 am Sale | 2025-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 1,401,576 2.640% | -2,174,388 (-60.81%) | Filing History |
| 2025-11-13 09:07 am Sale | 2025-09-30 | 13G | Solid Biosciences Inc. SLDB | Adage Capital Management, L.P. | 4,000,000 5.140% | -2,729,484 (-40.56%) | Filing History |
| 2025-11-13 09:07 am Unchanged | 2025-09-30 | 13G | Traws Pharma, Inc. TRAW | Adage Capital Management, L.P. | 330,000 4.670% | 0 (Unchanged) | Filing History |
| 2025-11-13 09:07 am Sale | 2025-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 5,559,782 8.070% | -1,240,218 (-18.24%) | Filing History |
| 2025-11-13 09:06 am Purchase | 2025-09-30 | 13G | Centessa Pharmaceuticals plc CNTA | Adage Capital Management, L.P. | 10,035,000 7.480% | 1,632,000 (+19.42%) | Filing History |
| 2025-11-13 09:05 am Sale | 2025-09-30 | 13G | Aclaris Therapeutics, Inc. ACRS | Adage Capital Management, L.P. | 5,278,144 4.870% | -2,923,200 (-35.64%) | Filing History |
| 2025-11-13 09:05 am Sale | 2025-09-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Adage Capital Management, L.P. | 6,816,828 6.390% | -1,983,172 (-22.54%) | Filing History |
| 2025-11-13 09:05 am Sale | 2025-09-30 | 13G | MeiraGTx Holdings plc MGTX | Adage Capital Management, L.P. | 4,184,578 5.200% | -1,044,521 (-19.98%) | Filing History |
| 2025-11-13 09:04 am Purchase | 2025-09-30 | 13G | Adagio Medical Holdings, Inc. ADGM | Adage Capital Management, L.P. | 1,058,501 6.880% | 237,240 (+28.89%) | Filing History |
| 2025-11-13 09:03 am Purchase | 2025-09-30 | 13G | OTG Acquisition Corp. I Unit OTGAU | Adage Capital Management, L.P. | 1,800,000 7.570% | 1,800,000 (New Position) | Filing History |
| 2025-11-13 09:03 am Sale | 2025-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | Adage Capital Management, L.P. | 2,432,000 4.500% | -2,157,000 (-47.00%) | Filing History |
| 2025-11-13 09:03 am Purchase | 2025-09-30 | 13G | Galata Acquisition Corp. II Units LATAU | Adage Capital Management, L.P. | 1,350,000 7.830% | 1,350,000 (New Position) | Filing History |
| 2025-11-13 09:02 am Purchase | 2025-09-30 | 13G | BridgeBio Oncology Therapeutics Inc. BBOT | Adage Capital Management, L.P. | 1,487,621 1.880% | 1,487,621 (New Position) | Filing History |